CURE’s prostate cancer page is an extensive resource of cancer information featuring the latest prostate cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on prostate cancer.
March 15th 2019
From FDA news to today’s top performers and entertainers, here’s what’s making headlines in the cancer space this week.
February 1st 2019
In topline findings from the phase 3 TITAN trial (NCT02489318) announced today by Janssen, Erleada (apalutamide) in combination with androgen deprivation therapy (ADT) significantly improved radiographic progression-free survival (rPFS) and overall survival (OS) versus placebo in patients with metastatic castration-sensitive prostate cancer.
February 1st 2019
A prostate cancer survivor offers his thoughts on what you should (and shouldn't) say to someone who was recently diagnosed.
December 15th 2018
Men with advanced prostate cancer may benefit from genomic testing as BRCA and other gene mutations play a bigger role in guiding treatment.
November 21st 2018
One patient opted to focus on his interests instead of focusing on cancer.
November 16th 2018
Whether you call it No Shave November, Movember or Novembeard, it's important to remember it's all about men's health.
November 11th 2018
Most men with the disease should keep their prostates, says the author of a book about prostate cancer staging and treatment.
November 9th 2018
A clinical trial will test a radiation regimen designed to preserve sexual function in men being treated for prostate cancer.
November 4th 2018
It's more than the beard. It's about men's health.
October 23rd 2018
A high dose of precision radiation could drastically increase the survival rates of patients with metastatic cancer, and double the time patients live without cancer growth, according to study results presented at the 60th Annual Meeting of the American Society for Radiation Oncology.
October 22nd 2018
Although there is never the perfect time to have a risk-related discussion with a child, one clinical psychologist explains ways in which parents can approach the difficult topic.
October 20th 2018
A genetic counselor discussed the various hereditary breast and ovarian cancer syndrome-associated cancers among men and how to manage them at the FORCE Annual Meeting.
October 2nd 2018
The FDA has granted the PARP inhibitor Rubraca (rucaparib) a breakthrough therapy designation for single-agent use in adult patients with BRCA1/2-positive metastatic castration-resistant prostate cancer (mCRPC) following at least one androgen receptor–directed therapy and taxane-based chemotherapy.
October 1st 2018
Here are the top 5 CURE stories for September 2018.
September 19th 2018
Prostate cancer is one of the most common cancers in males, with about one man in nine to be diagnosed during his lifetime, according to the American Cancer Society.
September 1st 2018
Family history was one indicator that a man should undergo periodic screening, but it wasn’t until a couple of decades ago that scientists confirmed a link between inherited mutations of the BRCA gene and the development of prostate cancer.
July 5th 2018
Here's how one expert decides on the next steps in treatment when a man with prostate cancer has a rising PSA and no visible metastases.
July 2nd 2018
Take a look at the top five CURE stories of June 2018 in this video.
June 27th 2018
We've come a long way in determining which patients with prostate cancer to treat, but there is still more work that needs to be done.
June 20th 2018
There are some key discussions that men with metastatic prostate cancer should have with their health care providers.
June 12th 2018
It is important that advocacy organizations unify their message, says Mike Crosby, the founder of the Veterans Prostate Cancer Awareness group.
June 12th 2018
The FDA approved the Paxman Scalp Cooling System for patients with solid tumors who wish to prevent chemotherapy-related hair loss.
June 7th 2018
Over the past few decades, prostate cancer has become better understood and treated more effectively.
May 24th 2018
The Food and Drug Administration (FDA) approved a new formulation of Yonsa (abiraterone acetate) in combination with methylprednisolone as a treatment for men with metastatic castration-resistant prostate cancer (mCRPC), according to Sun Pharma, the company commercializing the treatment.
May 23rd 2018
The group came together to discuss gaps in knowledge concerning the prostate cancer journey, including nonmetastatic castration-resistant prostate cancer (nmCRPC) and metastatic disease.
April 10th 2018
As part of the Prostate Cancer Foundation’s first annual campaign, Kristen Bell selected two winners because of their ‘candor and honesty’ to be honored.
April 5th 2018
After his own journey with prostate cancer, radio and TV personality Ed Randall used his extensive connections throughout professional sports to spread awareness about prostate cancer through his nonprofit organization Fans for the Cure.